Marvin Ilacas De los Santos
  • Senior Research Scientist, Globetek Science Foundation
Research focus
  • Immunology
  • Cancer Biology
    Biological Therapeutics
    Cellular Therapy
    Immune Engineering
    T cell biology
    Molecular Immunology
    Autoimmune Disease
    Immunotherapy
  • 1 Author merit

Lab information

https://globetekscientific.wixsite.com/home

Publications

http://systems.enpress-publisher.com/index.php/ti/article/view/1064/826
CAR-T Therapy for Solid Tumors: Development of New Strategies (Trends in Immunotherapy)
1 Protocol published
Cellular Retention Assay to Determine the Interaction Frequency of CD19-directed Chimeric Antigen Receptor (CAR) Engineered Cells against CD19+ Leukemic Cells
Authors:  Marvin I. De los Santos and Samuel D. Bernal, date: 09/05/2019, view: 224, Q&A: 0
Cancer recognition by chimeric antigen receptor T (CAR-T) cell is prerequisite for cancer killing to occur. Anomalies in the binding specificity of scFv in the CAR construct may prevent successful eradication of these cancer cells. In some cases, ...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.